Dr. Howard Kaufman  Dr. Howard Kaufman (Handout / March 28,
2012)  According to studies published last week in The Lancet,
taking a daily dose of aspirin can reduce the risk of cancer.
The new studies, led by Peter Rothwell of Britain's Oxford
University, found that low-dose aspirin has a short-term benefit
in preventing cancer and can reduce the risk of some cancers by
as much as 50 percent.  For further clarification, we turned to
Dr. Howard Kaufman, director of the Rush University Cancer
Center at Rush University Medical Center. His primary research
interest is melanoma and tumor immunotherapy, and he has more
than 120 articles and other publications to his credit. Here's
what he had to say about this cheap, over-the-counter pill
that's in nearly everyone's medicine chest:  Q. What have we
learned from these findings?  View/Submit Comments for this
story  A. I think we've suspected aspirin had a beneficial role
to play in preventing cancer, and these two long-term studies go
a long way in supporting that